Author(s)

Maduike C. O. Ezeibe^*, Favour Onyeachonam, Mary E. Sanda, Ijeoma J. Ogbonna, Ekenma Kalu, Njoku U. Njoku, Munachi Udobi

College of Veterinary Medicine, Michael Okpara University of Agriculture, Umudike, Nigeria.

COVID-19 virus has positive electrical charges. So, particles that are negatively charged would, by opposite charges-electrostatic attraction, inhibit its replication’s first stage (attachment to cells) and mop its extra-cellular particles. Positively charged particles would similarly mop/destroy cells it infects because unlike healthy cells which are neutral, infected/tumor cells have negative electrical charges. Nanoparticles (0.96 nm) of Aluminum-magnesium silicate (AMS), WHO-approved medicine/adjuvant have both negative and positive charged ends. As adjuvant it improves antimicrobials’ efficacies (clearing secondary infections) while as silicate it enhances immunity. By inhibiting viral replication; mopping extra-cellular viruses/abnormal cells; clearing secondary infections; enhancing immunity, AMS terminates viral-infections/abnormal cells’ metastases. Natural AMS has impurities and its deposits are not found in Nigeria. So, Aluminum silicate and Magnesium silicate (WHO-approved medicines) were used for Medicinal synthetic AMS {MSAMS: Al₄ (SiO₄)₃ + 3Mg₂SiO₄ → 2Al₂Mg₃ (SiO₄)₃}. Since AMS is un-absorbable, dextrose monohydrate is incorporated in MSAMS-formulations to convey its Nanoparticles into blood for circulation to all organs/tissues (active-transportation). The MSAMS achieved quick cure (within 3 days) of all four COVID-19 patients used for its first-phase trial (one in Nigeria, two in Cameroon, one in Tanzania).

COVID-19, Medicinal Synthetic Aluminum-Magnesium Silicate, Opposite Charges’ Electrostatic Attraction, Quick Cure

Ezeibe, M. , Onyeachonam, F. , Sanda, M. , Ogbonna, I. , Kalu, E. , Njoku, N. and Udobi, M. (2021) Electrostatic Mopping of Viruses with Medicinal Synthetic Aluminum-Magnesium Silicate {Al₄(SiO₄)₃ + 3Mg₂SiO₄ → 2Al₂Mg₃(SiO₄)₃}, for Quick Cure of COVID-19: A Better Control Measure. Open Journal of Epidemiology, 11, 278-283. doi: 10.4236/ojepi.2021.113024.